D. E. Shaw & Co., Inc. Seres Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 486,353 shares of MCRB stock, worth $350,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares

486,353

Previous 168,518 188.61%

Holding current value

$350,174

Previous $235,000 59.15%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.75 - $1.56 $238,376 - $495,822	317,835 Added 188.61%	486,353 $374,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $156,721 - $362,313	168,518 New	168,518 $235,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $141,723 - $399,973	-52,490 Reduced 54.88%	43,148 $148,000
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $418,987 - $587,913	66,506 Added 228.29%	95,638 $681,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $77,922 - $147,949	12,944 Added 79.96%	29,132 $243,000

Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $198,154 - $820,199	-36,292 Reduced 69.15%	16,188 $113,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $6,682 - $8,818	362 Added 0.69%	52,480 $1.25 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $6.06 Million - $9.92 Million	-342,883 Reduced 86.81%	52,118 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $2.39 Million - $3.88 Million	-102,934 Reduced 20.67%	395,001 $9.68 Million
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $1.19 Million - $9.12 Million	-317,227 Reduced 38.92%	497,935 $14.1 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $990,988 - $2.02 Million	325,983 Added 66.64%	815,162 $3.88 Million
Q1 2020 May 15, 2020	BUY	$2.64 - $3.82 $337,299 - $488,062	127,765 Added 35.35%	489,179 $1.75 Million
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $309,273 - $457,187	103,436 Added 40.09%	361,414 $1.25 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $132,465 - $240,635	-57,845 Reduced 18.32%	257,978 $1.03 Million
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $69,581 - $224,307	30,518 Added 10.7%	315,823 $1.02 Million
Q1 2019 May 15, 2019	SELL	$4.83 - $7.21 $109,278 - $163,126	-22,625 Reduced 7.35%	285,305 $1.96 Million
Q4 2018 Feb 14, 2019	BUY	$4.52 - $8.88 $77,716 - $152,682	17,194 Added 5.91%	307,930 $1.39 Million
Q3 2018 Nov 14, 2018	BUY	$7.33 - $9.23 $13,003 - $16,374	1,774 Added 0.61%	290,736 $2.21 Million
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $78,324 - $108,249	-11,335 Reduced 3.77%	288,962 $2.49 Million
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $588,198 - $894,317	-80,136 Reduced 21.06%	300,297 $2.2 Million
Q4 2017 Feb 14, 2018	SELL	$9.15 - $12.64 $1.54 Million - $2.13 Million	-168,315 Reduced 30.67%	380,433 $3.86 Million
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $7.03 Million - $9.25 Million	548,748	548,748 $8.8 Million

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account